JANE STREET GROUP, LLC - SEELOS THERAPEUTICS INC ownership

SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 84 filers reported holding SEELOS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$7,995
-36.7%
43,451
+137.7%
0.00%
Q1 2023$12,637
-25.7%
18,283
-26.7%
0.00%
Q2 2022$17,000
-39.3%
24,951
-25.4%
0.00%
Q1 2022$28,000
-81.0%
33,460
-63.1%
0.00%
Q4 2021$147,000
-68.7%
90,775
-53.3%
0.00%
Q3 2021$469,000
-18.9%
194,300
-11.2%
0.00%
Q2 2021$578,000
-76.6%
218,884
-55.7%
0.00%
-100.0%
Q1 2021$2,466,000
+10621.7%
494,135
+3240.6%
0.00%
Q4 2020$23,000
+91.7%
14,792
+25.6%
0.00%
Q2 2020$12,000
-92.9%
11,777
-76.5%
0.00%
Q1 2019$168,00050,1000.00%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
GENDELL JEFFREY L 4,933,024$4,133,0000.30%
ACUTA CAPITAL PARTNERS, LLC 295,896$248,0000.12%
Connacht Asset Management LP 231,551$194,0000.10%
Uniplan Investment Counsel, Inc. 1,564,605$1,310,0000.08%
AdvisorShares Investments LLC 358,796$301,0000.05%
1492 Capital Management LLC 99,819$84,0000.04%
Woodline Partners LP 2,803,230$2,349,0000.04%
Ikarian Capital, LLC 257,883$215,0000.03%
Sovereign Financial Group, Inc. 75,000$63,0000.02%
Aquatic Capital Management LLC 6,400$5,0000.01%
View complete list of SEELOS THERAPEUTICS INC shareholders